Iterum Therapeutics Plc (ITRMF)
0.055
+0.01
(+29.72%)
USD |
OTCM |
May 06, 16:00
Iterum Therapeutics Cash from Investing (Quarterly) : -0.0126M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp. Plc | -8.284M |
| Jazz Pharmaceuticals Plc | 123.10M |
| Prothena Corp. Plc | 0.002M |
| GH Research Plc | 8.566M |
| Cosmo Pharmaceuticals NV | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.855M |
| Cash from Financing (Quarterly) | 5.655M |
| Free Cash Flow | -19.63M |
| Free Cash Flow Per Share (Quarterly) | -0.1718 |
| Free Cash Flow to Equity (Quarterly) | -9.044M |
| Free Cash Flow to Firm (Quarterly) | -7.297M |
| Free Cash Flow Yield | -974.4% |